This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
See a global view of dividend ETFs and understand which regions offer the strongest yields, risk, and diversification for your strategy.
10,327 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Bitcoin has quieted its swings, but risk-aware investors are still buying protection. This guide explains why hedges ...
asml stock popped today as investors chased AI-driven demand for semiconductor equipment. This guide breaks down what...
A surge in Planet Labs shares has traders buzzing. This guide explains the drivers behind the move, the risks involve...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
Retail investors chasing nat gas bets via front-month futures confront a hidden drag. The roll yield trap that gnaws ...
Micron stock surged 700% over the past year, driven by AI memory demand. This guide breaks down what powered the rall...
Two heavyweight names in cloud security are navigating a shifting enterprise landscape. This analysis dives into the ...
Oil markets face renewed Hormuz-related risk as traders debate a potential NACHO scenario. Could trump nacho trade re...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
JEPQ offers a near-9.5% yield by pairing Nasdaq-100 stocks with equity-linked notes. But the unsecured counterparty r...
Tesla's robotaxi venture is facing real-world hurdles in Texas. This article breaks down what those problems mean for...